PREPA PREvention of Loss of Autonomy
PREPA
Prevention Study on Loss of Autonomy and Physical Dependence, Based on Physical Exercises and Nutrition Counseling Applied to Old People.
1 other identifier
interventional
530
1 country
1
Brief Summary
According to several reports, the proportion of people aged 80yrs or older will be doubled within the next 25y, reaching 10% of the global population. Furthermore, the health life expectancy at 65y is 10.4y which remains much lower than the general life expectancy. As a result, there is a constant need of developing preventive strategies through multimodal programs. Among the predictive factors of mobility disability with age, muscular weakness and decreased physical function are major components. These two factors are known of being responsible for falls and fractures that lead to decrease the quality of life and an increase in mortality. Exercise and nutrition are the only components that have proven their efficacy to struggle mobility disability risk. It is important to integrate these two components in a sustained intervention within a multidimensional prevention program. However, there is a lack of implementation of these programs in primary care. Indeed, neither the screening of older adults at risk of mobility disability, nor the preventive actions are usually implemented for this population. The implementation of a prevention care pathway, with personalized intervention and a sustained follow-up, along with supervised exercise training combined with nutritional counselling, is the public health imperatives. Based on prevention care pathway that designed for community-dwelling older adults screened at risk of mobility disability. The purpose of this open cohort study was to highlight the efficacy and the feasibility of a multimodal program implemented on real-life setting specifically on the physical function and risk of mobility loss, along with their maintenance at 6-months and 1-year follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 29, 2018
CompletedStudy Start
First participant enrolled
July 10, 2018
CompletedFirst Posted
Study publicly available on registry
September 12, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2025
CompletedSeptember 9, 2025
June 1, 2025
7.2 years
January 29, 2018
September 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Functional status
Functional status is assessed using the overall SPPB (Short Physical Performance Battery) score based on three components: 6 meters usual walking speed, 5 repetitions chair stand test, and static balance tests. (composite score /12). The SPPB score is calculate from the results in 3 subtests. It ranges from 1 to 12 points. Clinically meaningful change is 1 point.
initial assessment (baseline), following the exercise program (month 3), last visit (month 15)
Secondary Outcomes (27)
Evaluation of effectiveness on muscle strength : Handgrip test (kg)
initial assessment (baseline), following the exercise program (month 3), last visit (month 15)
Evaluation of effectiveness on muscle strength : Maximal isometric strength of the quadriceps (kg)
initial assessment (baseline), following the exercise program (month 3), last visit (month 15)
Evaluation of effectiveness on functional status : 5 repetitions chair stand test (s)
initial assessment (baseline), following the exercise program (month 3), last visit (month 15)
Evaluation of effectiveness on functional status : Time in TUG (s)
initial assessment (baseline), following the exercise program (month 3), last visit (month 15)
Evaluation of effectiveness on functional status : Lower body muscle power measured by a one sit-to-stand test perform at maximum speed (Neurocom Balance Master, Medimex®, France)
initial assessment (baseline), following the exercise program (month 3)
- +22 more secondary outcomes
Study Arms (1)
Multicomponent group-based supervised exercise program
OTHERCommunity-dwelling older adults aged of \>70y, screened at risk of mobility disability risk factors and assessed with at least 1 mobility disability risk factor (see intervention 1). These subjects are included in the protocol and participate in a multicomponent exercise program.
Interventions
Evaluation carried out during a day hospital at T0 (initial assessment) and T3 following the exercise program including: 1. Clinical assessment by a geriatrician 2. Nutritional assessment 3. Physical capacity assessment Following initial assessment (T0), older adults are included in the multicomponent exercise program if they present mobility disability risk factors including : * At least pre-frailty regarding Fried frailty criteria AND/OR * At least probable sarcopenia regarding EWGSOP2 algorithm AND/OR * The presence of at least an intermediate fall risk AND/OR * The presence of a fear of falling Following the exercise program (T3), all participants are re-assessed in the same way as T0. Investigators then set goals in physical activity with participants to maintain benefits and foster self-engagement in an healthy lifestyle. Additionnally, participants are orientated to exercise facilities and received an individualized booklet of exercises for home-based training.
The intervention consists in a progressive multicomponent exercise training protocol. There are 2 sessions per week of 1 hour each for a total of 12 weeks. Sessions involve functional, resistance and balance exercises. Intensity is based on rating perceived effort (Borg's scale CR1-10) and volume towards 1 to 3 sets of 6 to 15 repetitions. Progressiveness in intensity and volume was based on effort tolerance, contraction regimen, velocity and load. Training schedule is described elsewhere (Delaire et al, 2023 ; doi.org/10.3390/nu15194100). Participants are allocated to an homogenous group based on functional status and cardiorespiratory comorbidities. Trained kinesiologists supervised the exercise program. Participants used free weights and elastic bands.
Follow-up at T3+6 months: Investigators interviewed participants for 30 minutes. During the interview, data collection include:record of undesirable events in the interval T3 / T3+6 (falls, unscheduled hospitalization, illness, institutionalization), medication changes, ADL, IADL, FES-I, and RAPA. Goal-settings at T3 are adjusted if not reach. Finally, investigators stimulate intrinsic motivation for PA. Follow-up at T3 + 12 months: Investigators re-assessed physical capacity, physical activity level, quality of life, fall risk and frailty for the last visit. Data collection include: * SPPB * Handgrip test and maximal isometric strength of the quadriceps * Questionnaires : SarQoL©, FES-I, RAPA * Gait quality analysis using inertial sensors * Undesirable events in the interval T3+6 / T3+12 (falls, unscheduled hospitalization, illness, institutionalization) * Medication changes * Body mass index * ADL and IADL At last, goals in physical activity are adjusted if they are still not reach
Eligibility Criteria
You may qualify if:
- Patient eligible for the "mobility loss prevention" program
- At least one of the following signs:
- Difficulty carrying a loaded shopping basket (about 4.5 kg)
- Difficulty rising from a chair without using the arms
- Difficulty climbing one flight of stairs (10 steps)
- Difficulty moving around
- Slowed walking
- Difficulty walking more than 400 meters without stopping
- Walking time \< 30 minutes/day
- Fatigue during mild physical efforts: running errands, household chores; fear of falling and/or at least one fall in the past year
- Recent unintentional weight loss: weight loss ≥ 5% in 6 months or BMI \< 22 kg/m²
You may not qualify if:
- Patient who has not given consent to participate
- Patient under guardianship in retrospective phase
- Locomotor disability
- expectancy of life being under 12 months
- BMI ≥ 35 Kg/m2
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service de Médecine Gériatrique Groupement Hospitalier Sud
Pierre-Bénite, 69495, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 29, 2018
First Posted
September 12, 2018
Study Start
July 10, 2018
Primary Completion
October 1, 2025
Study Completion
October 1, 2025
Last Updated
September 9, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share